These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2976620)

  • 21. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.
    Fazle Akbar SM; Furukawa S; Yoshida O; Hiasa Y; Horiike N; Onji M
    J Hepatol; 2007 Jul; 47(1):60-6. PubMed ID: 17467112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines.
    Zuckerman JN; Zuckerman AJ; Symington I; Du W; Williams A; Dickson B; Young MD;
    Hepatology; 2001 Oct; 34(4 Pt 1):798-802. PubMed ID: 11584378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.
    Sam MR; Shokrgozar MA; Shokri F
    Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

  • 30. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
    Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
    Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination.
    Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW
    Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
    Sylvan SP; Hellström UB; Lundbergh PR
    Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with recombinant HBsAg-HBIG complex in healthy adults.
    Xu DZ; Huang KL; Zhao K; Xu LF; Shi N; Yuan ZH; Wen YM
    Vaccine; 2005 Apr; 23(20):2658-64. PubMed ID: 15780449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
    Lu CY; Ni YH; Chiang BL; Chen PJ; Chang MH; Chang LY; Su IJ; Kuo HS; Huang LM; Chen DS; Lee CY
    J Infect Dis; 2008 May; 197(10):1419-26. PubMed ID: 18444799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of hepatitis B--HLA DR/DQ in HBs Ag nonresponder].
    Ouchi E; Hoshino A; Miura T; Nagahara N; Kudo Y; Tamura M
    Rinsho Byori; 1989 Nov; 37(11):1193-9. PubMed ID: 2601078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of antibodies and assessment of an international unit of anti-HBs specific immunoglobulin, HEPAGA].
    Kselíková M; Horejsí J; Urbánková J
    Cas Lek Cesk; 1989 Jun; 128(25):777-80. PubMed ID: 2527600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.